Instead, HER2-TAC-T cells accumulated primarily within tumor tissue, whereas little accumulation of HER2-CAR-T cells or control T cells was observed within the experimental time frame (Supplementary Fig. 8D, E), consistent with the delayed tumor control exhibited by the HER2-CAR-T cells. The gene discussed is ERBB2; the disease is neoplasm.